偶然但非无关紧要:Graves病患者中的甲状腺癌
该单中心回顾性研究纳入2011至2023年因Graves病行甲状腺全切除术的934例患者,术后病理偶然发现甲状腺癌60例(6.4%),以甲状腺乳头状癌为主(58.3%),其次为甲状腺微小乳头状癌(33.3%);术前超声和细针穿刺常不能可靠预测甲状腺癌。
要点
- 因Graves病行甲状腺全切除术的患者中,术后病理偶然发现甲状腺癌的比例为6.4%。
- 偶然发现的甲状腺癌中,甲状腺乳头状癌占58.3%,甲状腺微小乳头状癌占33.3%。
- 术前超声发现结节者中仅13.7%最终病理为甲状腺癌,细针穿刺常报告良性。
核心结论
- 因Graves病行甲状腺全切除术的患者中,6.4%在手术病理中偶然发现甲状腺癌。
- 术前超声和细针穿刺常不能可靠预测甲状腺癌。
- 在向患者咨询Graves病的根治性治疗选择时,不应低估甲状腺癌的发生率。
研究设计与样本
- 单中心回顾性研究,回顾2011至2023年因Graves病行甲状腺全切除术的患者。
- 共纳入934例患者,比较有与无偶然甲状腺癌患者在人口学、术前实验室与影像评估、术前内科治疗及手术结局方面的差异。
主要发现
- 934例患者中60例(6.4%)术后病理偶然发现甲状腺癌。
- 偶然发现的甲状腺癌中,甲状腺乳头状癌占58.3%,甲状腺微小乳头状癌占33.3%。
- 564例(60.4%)患者接受术前超声,其中44.3%发现结节,但结节患者中仅34例(13.7%)最终病理为甲状腺癌。
- 15例甲状腺癌患者接受术前细针穿刺,其中8例(53.3%)报告为良性病变,最终病理为甲状腺癌。
- 两组在性别、种族或民族、术前内科治疗及术后结局方面无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Graves disease is the most common cause of hyperthyroidism in the US. Treatment with antithyroid drugs and radioactive iodine is more commonly used than surgical management with total thyroidectomy (TTx). However, incidentally discovered thyroid cancer (TC) has been described on surgical pathology from patients who underwent surgical treatment of Graves disease, which would be missed with these other treatment strategies. We sought to determine the incidence rate of TC among patients with surgically treated Graves disease. STUDY DESIGN: We retrospectively reviewed patients with Graves disease who underwent TTx at a single institution from 2011 to 2023. Pathology reports were reviewed for TC. Patient demographics, preoperative laboratory and radiological evaluations, preoperative medical management, and surgical outcomes were compared between patients with and without incidental TC. RESULTS: There were 934 patients, of whom 60 (6.4%) patients had incidentally discovered TC on pathology. The majority (58.3%) of patients had papillary thyroid carcinoma, followed by 33.3% with papillary microcarcinoma. Preoperative ultrasound (US) was obtained in 564 (60.4%) of patients, with 44.3% with nodules, but only 34 (13.7%) of those with nodules had TC on final pathology. Preoperative fine needle aspiration was obtained in 15 patients with TC, and 8 patients (53.3%) were reported as benign lesions, which ultimately had TC on final pathology. There was no difference in sex, race or ethnicity, preoperative medical management, and postoperative outcomes between the 2 groups. CONCLUSIONS: Incidental TC was found on surgical pathology in 6.4% of patients undergoing TTx for Graves disease. Preoperative imaging with US and fine needle aspiration were often unreliable at predicting TC. The incidence of TC should not be underestimated when counseling patients on definitive management for Graves disease.
引用
- Wang R, Disharoon M, Song Z, et al. Incidental but Not Insignificant: Thyroid Cancer in Patients with Graves Disease. J Am Coll Surg. 2024. PMID: 38230856. doi:10.1097/XCS.0000000000000973
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。